Clinical and Imaging Follow-Up for High-Risk Cutaneous Melanoma: Current Evidence and Guidelines
Author:
Open Access
Abstract
The most recent (eighth) edition of the American Joint Committee on Cancer (AJCC) staging system divides invasive cutaneous melanoma into two broad groups: “low-risk” (stage IA–IIA) and “high-risk” (stage IIB–IV). While surveillance imaging for high-risk melanoma patients makes intuitive sense, supporting data are limited in that they are mostly respective and used varying methods, schedules, and endpoints. As a result, there is a lack of uniformity across different dermatologic and oncologic organizations regarding recommendations for follow-up, especially regarding imaging. That said, the bulk of retrospective and prospective data support imaging follow-up for high-risk patients. Currently, it seems that either positron emission tomography (PET) or whole-body computerized tomography (CT) are reasonable options for follow-up, with brain magnetic resonance imaging (MRI) preferred for the detection of brain metastases in patients who can undergo it. The current era of effective systemic therapies (ESTs), which can improve disease-free survival (DFS) and overall survival (OS) beyond lead-time bias, has emphasized the role of imaging in detecting various patterns of EST response and treatment relapse, as well as the importance of radiologic tumor burden.Keywords
This publication has 43 references indexed in Scilit:
- Diagnostic accuracy of contrast-enhanced CT versus PET/CT for advanced ovarian cancer staging: a comparative systematic review and meta-analysisAbdominal Radiology, 2024
- Metastasectomy for metastatic melanoma in the era of effective systemic therapyThe American Journal of Surgery, 2023
- Routine imaging guided by a 31-gene expression profile assay results in earlier detection of melanoma with decreased metastatic tumor burden compared to patients without surveillance imaging studiesArchives of Dermatological Research, 2023
- Circulating tumour DNA (ctDNA) in metastatic melanoma, a systematic review and meta-analysisEuropean Journal of Cancer, 2021
- Utility of a 31-gene expression profile for predicting outcomes in patients with primary cutaneous melanoma referred for sentinel node biopsyThe American Journal of Surgery, 2021
- Imaging in Cutaneous Melanoma: Which Test to Order and When?The Laryngoscope, 2021
- Imaging of gastrointestinal melanoma metastases: Correlation with surgery and histopathology of resected specimenEuropean Radiology, 2016
- Prospective evaluation of follow-up in melanoma patients in Germany – Results of a multicentre and longitudinal studyEuropean Journal of Cancer, 2015
- Follow-up schedules after treatment for malignant melanomaBritish Journal of Surgery, 2008
- PET recognition of pulmonary metastases on PET/CT imaging: impact of attenuation-corrected and non-attenuation-corrected PET imagesEuropean Journal of Nuclear Medicine and Molecular Imaging, 2005